4.7 Article

Environmental factors associated with disease flare in juvenile and adult dermatomyositis

Journal

RHEUMATOLOGY
Volume 56, Issue 8, Pages 1342-1347

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/rheumatology/kex162

Keywords

dermatomyositis; juvenile dermatomyositis; disease flare; environmental factors

Categories

Funding

  1. Intramural Research Programme of the National Institutes of Health, National Institute of Environmental Health Sciences

Ask authors/readers for more resources

Objective. The aim was to assess environmental factors associated with disease flare in juvenile and adult dermatomyositis (DM). Methods. An online survey of DM patients from the USA and Canada examined smoking, sun exposure, infections, medications, vaccines, stressful life events and physical activity during the 6 months before flares, or in the past 6 months in patients without flares. Differences were evaluated by chi(2) and Fisher's exact tests, and significant univariable results were examined in multivariable logistic regression. Residential locations before flare were correlated with the National Weather Service UV index. Results. Of 210 participants (164 juvenile and 46 adult DM), 134 (63.8%) experienced a disease flare within 2 years of the survey. Subjects more often reported disease flare after sun exposure [odds ratio (OR) = 2.0, P = 0.03], although use of photoprotective measures did not differ between those with and without flare. Urinary tract infections (OR = 16.4, P = 0.005) and gastroenteritis (OR = 3.2, P = 0.04) were more frequent in the preceding 6 months in those who flared. Subjects who flared recently used NSAIDS (OR = 3.0, P = 0.0003), blood pressure medicines (OR = 3.5, P = 0.049) or medication for depression or mood changes (OR = 12.9, P = 0.015). Moving to a new house (OR = 10.3, P = 0.053) was more common in those who flared. Only sun exposure (OR = 2.2) and NSAIDs (OR = 1.9) were significant factors in multivariable analysis. Conclusion. Certain classes of environmental agents that have been associated with the initiation of DM, including sun exposure and medications, may also play a role in disease flares.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Rheumatology

Response to: 'Correspondence on 'EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups'' by Irfan et al

Ingrid E. Lundberg, Frederick W. Miller, Lisa G. Rider, Victoria P. Werth, Anna Tjarnlund, Matteo Bottai

ANNALS OF THE RHEUMATIC DISEASES (2023)

Article Rheumatology

Anti-FHL1 autoantibodies in juvenile myositis are associated with anti-Ro52 autoantibodies but not with severe disease features

Matthew A. Sherman, Rose Graf, Sara E. Sabbagh, Angeles S. Galindo-Feria, Iago Pinal-Fernandez, Katherine Pak, Takayuki Kishi, Willy A. Flegel, Ira N. Targoff, Frederick W. Miller, Ingrid E. Lundberg, Lisa G. Rider, Andrew L. Mammen

Summary: This study found the presence of anti-FHL1 autoantibodies in juvenile IIM patients, which were associated with MAAs and specific skin rash, but not with other clinical features or worse outcomes.

RHEUMATOLOGY (2023)

Letter Critical Care Medicine

Human Leukocyte Antigen Alleles Associated with Interstitial Lung Disease in North Americans with Idiopathic Inflammatory Myopathy

Cheilonda Johnson, Adam I. Schiffenbauer, Frederick W. Miller, Jamie Perin, Sonye K. Danoff, Avantika R. Diwadkar, Jaehyun Joo, Blanca E. Himes, Nuala J. Meyer

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2023)

Article Rheumatology

Low copy numbers of complement C4 and C4A deficiency are risk factors for myositis, its subgroups and autoantibodies

Danlei Zhou, Emily H. King, Simon Rothwell, Olga Krystufkova, Antonella Notarnicola, Samantha Coss, Rabheh Abdul-Aziz, Katherine E. Miller, Amanda Dang, G. Richard Yu, Joanne Drew, Emeli Lundstrom, Lauren M. Pachman, Gulnara Mamyrova, Rodolfo Curiel, Boel De Paepe, Jan L. De Bleecker, Antony Payton, William Ollier, Terrance P. O'Hanlon, Ira N. Targoff, Willy A. Flegel, Vidya Sivaraman, Edward Oberle, Shoghik Akoghlanian, Kyla Driest, Charles H. Spencer, Yee Ling Wu, Haikady N. Nagaraja, Stacy P. Ardoin, Hector Chinoy, Lisa G. Rider, Frederick W. Miller, Ingrid E. Lundberg, Leonid Padyukov, Jiri Vencovsky, Janine A. Lamb, Chack-Yung Yu

Summary: C4A deficiency is relevant in dermatomyositis, HLA-DRB1*03 is important in IBM, and both C4A deficiency and HLA-DRB1*03 contribute interactively to the risk of polymyositis.

ANNALS OF THE RHEUMATIC DISEASES (2023)

Article Rheumatology

Identification of Novel Associations and Localization of Signals in Idiopathic Inflammatory Myopathies Using Genome-Wide Imputation

Simon I. Rothwell, Christopher W. Amos, Frederick G. Miller, Lisa E. Rider, Ingrid K. Lundberg, Peter Gregersen, Jiri Vencovsky, Neil McHugh, Vidya Limaye, Albert G. Selva-O'Callaghan, Michael M. Hanna, Pedro M. Machado, Lauren M. Pachman, Ann Reed, Oyvind Molberg, Olivier Benveniste, Pernille Mathiesen, Timothy Radstake, Andrea L. Doria, Jan De Bleecker, Boel De Paepe, Britta E. Maurer, William Ollier, Leonid P. Padyukov, Terrance O'Hanlon, Annette R. Lee, Lucy Wedderburn, Hector A. Chinoy, Janine Lamb

Summary: In this study, genetic analysis of samples from patients with idiopathic inflammatory myopathies (IIMs) identified novel gene variants and localized signals to specific immune cell types. These findings provide new insights into the pathogenesis of IIMs.

ARTHRITIS & RHEUMATOLOGY (2023)

Article Rheumatology

Development of a computed tomography calcium scoring technique for assessing calcinosis distribution, pattern and burden in dermatomyositis

Briana A. Cervantes, Prateek Gowda, Lisa G. Rider, Frederick W. Miller, Marcus Y. Chen, Adam Schiffenbauer

Summary: This study used whole-body CT scans and calcium scoring techniques to assess calcinosis in patients with adult and juvenile dermatomyositis. Different patterns and new locations of calcinosis were observed using CT scans and the Agatston scoring method, which can effectively evaluate and track calcinosis in these patients.

RHEUMATOLOGY (2023)

Article Rheumatology

Association of anti-TPM4 autoantibodies with vasculopathic cutaneous manifestations in juvenile dermatomyositis

Rie Karasawa, Kazuo Yudoh, Toshiko Sato, Megumi Tanaka, Sara E. Sabbagh, Willy A. Flegel, Andrew L. Mammen, James N. Jarvis, Lisa G. Rider

Summary: By using Western blotting, the expression of TPM4 protein in normal human dermal microvascular ECs was investigated. Using ELISA, anti-TPM4 autoantibodies were detected in 30% of JDM plasma samples. These autoantibodies were associated with certain clinical features of JDM, such as cutaneous ulcers, shawl sign rash, mucous membrane lesions, and subcutaneous edema.

RHEUMATOLOGY (2023)

Article Rheumatology

Performance of the 2016 ACR-EULAR Myositis Response Criteria in adult dermatomyositis/polymyositis therapeutic trials and consensus profiles

Didem Saygin, Hanna Kim, Christian Douglas, Brian Erman, Jesse Wilkerson, John A. McGrath, Chester Oddis, Ingrid E. Lundberg, Anthony A. Amato, Ignacio Garcia-De La Torre, Hector Chinoy, David Fiorentino, Lorinda Chung, Yeong-Wook Song, Frederick W. Miller, Nicolino Ruperto, Jiri Vencovsky, Rohit Aggarwal, Lisa G. Rider

Summary: This study further validated the ACR-EULAR Myositis Response Criteria (MRC) by assessing the contribution of each core set measure, the frequency of improvement in strength vs extramuscular activity, the representation of patient-reported outcome measures (PROM), and the frequency of core set measure worsening. The results showed that improvement in strength was the main contributing factor, and the majority of patients also had improvement in PROM.

RHEUMATOLOGY (2023)

Article Rheumatology

Performance of the 2016 ACR-EULAR myositis response criteria in juvenile dermatomyositis therapeutic trials and consensus profiles

Hanna Kim, Didem Saygin, Christian Douglas, Jesse Wilkerson, Brian Erman, Angela Pistorio, John A. McGrath, Ann M. Reed, Chester Oddis, Claudia Bracaglia, Annet van Royen-Kerkhof, Blanca Bica, Pavla Dolezalova, Virginia P. L. Ferriani, Berit Flato, Ana G. Bernard-Medina, Troels Herlin, Frederick W. Miller, Jiri Vencovsky, Nicolino Ruperto, Rohit Aggarwal, Lisa G. Rider

Summary: The 2016 ACR-EULAR response criteria for JDM is a composite measure with six core set measures to calculate a total improvement score. This study evaluated the contribution of each measure, representation of muscle-related and patient-reported measures, and frequency of measure worsening across improvement categories. The results support the consistent performance of the ACR-EULAR MRC across multiple studies and its further use as an efficacy endpoint in JDM trials.

RHEUMATOLOGY (2023)

Article Rheumatology

Therapeutic Development in Polyarticular Course Juvenile Idiopathic Arthritis: Extrapolation, Dose Selection, and Clinical Trial Design

Laura E. Schanberg, Lily (Yeruk) Mulugeta, Bolanle Akinlade, Hermine I. Brunner, Jianmeng Chen, Robert A. Colbert, Vincent Delgaizo, Marc R. Gastonguay, Rachel Glaser, Lisa Imundo, Daniel J. Lovell, Jocelyn H. Leu, Nael M. Mostafa, Robert M. Nelson, Peter A. Nigrovic, Nikolay P. Nikolov, Lisa G. Rider, Rebecca Rothwell, Chandrahas Sahajwalla, Renu Singh, Vikram Sinha, Carolyn L. Yancey, Lynne Yao

Summary: This report summarizes a workshop on drug development for polyarticular juvenile idiopathic arthritis (pJIA), highlighting the importance of accelerating drug development and the necessity of collaboration between stakeholders.

ARTHRITIS & RHEUMATOLOGY (2023)

Article Rheumatology

Shared and Distinctive Transcriptomic and Proteomic Pathways in Adult and Juvenile Dermatomyositis

James M. Ward, Mythri Ambatipudi, Terrance P. O'Hanlon, Michael A. Smith, Melissa de Los Reyes, Adam Schiffenbauer, Saifur Rahman, Kamelia Zerrouki, Frederick W. Miller, Miguel A. Sanjuan, Jian-Liang Li, Kerry A. Casey, Lisa G. Rider

Summary: Transcript and protein expression were analyzed in active adult dermatomyositis (DM) and juvenile DM patients receiving immunosuppressive therapies. A total of 1,124 gene loci showed significant alterations in expression, with 70 genes shared between DM and juvenile DM. Interferon-stimulated genes and innate immune markers specific to neutrophils were up-regulated in both DM and juvenile DM. Pathway analysis revealed up-regulation of PI3K/AKT, ERK, and p38 MAPK signaling in DM, with different regulation of upstream and downstream components in both DM and juvenile DM. Therapeutic targets may include these pathways as well as neutrophil degranulation.

ARTHRITIS & RHEUMATOLOGY (2023)

Article Rheumatology

Autoantibodies Recognizing Specificity Protein 4 Co-occur With Anti-Transcription Intermediary Factor 1 and Are Associated With Distinct Clinical Features and Immunogenetic Risk Factors in Juvenile Myositis

Matthew A. Sherman, Katherine Pak, Iago A. Pinal-Fernandez, Willy A. N. Flegel, Ira N. W. Targoff, Frederick W. G. Miller, Lisa G. L. Rider, Andrew L. Mammen

Summary: This study investigated the prevalence and clinical features associated with anti-Sp4 autoantibodies in juvenile-onset idiopathic inflammatory myopathies (IIM). The results showed that anti-Sp4 autoantibodies were present in 7% of the juvenile myositis patients and were associated with coexisting anti-TIF1 autoantibodies and a reduced risk of cancer.

ARTHRITIS & RHEUMATOLOGY (2023)

Meeting Abstract Rheumatology

LOW GENE COPY NUMBERS OF COMPLEMENT C4 AND COMPLEMENT C4A DEFICIENCY ARE STRONG AND HIGHLY SIGNIFICANT GENETIC RISK FACTORS FOR IDIOPATHIC INFLAMMATORY MYOPATHY AND ITS MAJOR SUBGROUPS

Danlei Zhou, Emily H. King, Simon Rothwell, Olga Krystufkova, Antonella Notarnicola, Rabheh Abdul Aziz, Emeli Lundstrom, Stiburkova Blanka, Lauren M. Pachman, Gulnara Mamyrova, Boel de Paepe, Jan de Bleecker, Terrance P. O'Hanlon, Samantha Coss, Katherine Lintner Miller, Amanda Dang, G. Richard Yu, Joanne Drew, Vidya Sivaraman, Edward Oberle, Shoghik Akoghlanian, Kyla Driest, Charles H. Spencer, Yee Ling Wu, Stacy P. Ardoin, Lisa G. Rider, Hector Chinoy, Frederick W. Miller, Ingrid E. Lundberg, Leonid Padyukov, Jiri Vencovsky, Janine A. Lamb, Chack-Yung Yu

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY (2023)

Meeting Abstract Rheumatology

ASSOCIATION OF DECREASED NAILFOLD CAPILLARY END ROW LOOP (ERL) DENSITY AND DISEASE COURSE IN JUVENILE DERMATOMYOSITIS

Amer Khojah, Gabrielle Morgan, Najah Ahsan, Lauren M. Pachman

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY (2023)

Meeting Abstract Rheumatology

ASSOCIATION OF NAILFOLD CAPILLARY END ROW LOOP (ERL) PATTERN AND MYOSITIS SPECIFIC ANTIBODIES IN JUVENILE DERMATOMYOSITIS

Gabrielle Morgan, Amer Khojah, Sonia Savani, Najah Ahsan, Lauren M. Pachman

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY (2023)

No Data Available